Weekly E-Mail newsletter For physicians in Internal Medicine, Cardiology, Geriatrics, Women's Health, and Adolescent Medicine News from hundreds of top industry sources It's what clinicians need to know It's FREE!       Privacy Information       SmartBrief and AJM will not rent, sell, or trade your e-mail address to any external entities -- ever. Click here to read our Privacy Policy.       About SmartBrief About The American Journal of Medicine, published by Elsevier About Elsevier Visit other Elsevier Health Science publications     Send AJMPlus story to a colleague. * Your Name * Your E-mail * Friend's E-mail Separate multiple addresses with commas.   Personal Message * Indicates required fields Terms and Conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy. Here's the story you're sending: What lifestyle interventions can do in diabetes During follow-up after the Diabetes Prevention Program, incidences in the former placebo and metformin groups fell to equal those in the former lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group. Prevention or delay of diabetes with lifestyle intervention or metformin can persist for at least 10 years. (Free registration required.)  Lancet, The (10/29)